As an innovative company in the field of personalised medication, we are pleased to share the promising results of the PREPARE study, which was conducted by the international UPGx consortium.
In the PREPARE-Studiy („PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions“), the use of a drug passport containing genotyping of 12 genes and 50 genetic variants that affect drug degradation in the body was investigated.

After we were able to prove both our innovation capability and our digital competencies in the assessment series carried out by Bayern Innovativ, we are pleased that we can now also publish the excellent results of the sustainability assessment.
The assessment included a comprehensive evaluation of our sustainable environmental performance and social commitment. Our efforts to reduce our environmental footprint were especially highlighted. Last year, we already took successful measures to reduce our energy consumption, minimize waste and thus lower our emissions.

Our in-depth expertise in innovative technologies and sustainable business processes makes HMG Systems Engineering a pioneer in digital transformation.

To ensure that we are also positioned at the leading edge of our branch, Bayern Innovativ accompanied us at the end of last year in a second assessment on the topic of “digitalization”.

As of January 2023, HMG Systems Engineering is an official member of the established Canadian healthcare network MEDTEQ+ based in Montreal, Quebec. MEDTEQ+, with over 190 members, is a key player in the Canadian healthcare industry, bringing together leading companies, academic institutions and government agencies to promote the development and deployment of future-ready medical technologies.